human | Q5 |
P856 | official website | https://www.kennedy.ox.ac.uk/team/yoshi-itoh |
P496 | ORCID iD | 0000-0002-2128-2823 |
P108 | employer | University of Tokyo | Q7842 |
University of Oxford | Q34433 | ||
University of Kansas Medical Center | Q33526980 | ||
The Kennedy Institute of Rheumatology | Q49162809 | ||
P106 | occupation | researcher | Q1650915 |
Q33426480 | A compact, multidimensional spectrofluorometer exploiting supercontinuum generation. |
Q35077020 | ADAM10 controls collagen signaling and cell migration on collagen by shedding the ectodomain of discoidin domain receptor 1 (DDR1). |
Q79369367 | Ageladine A: an antiangiogenic matrixmetalloproteinase inhibitor from the marine sponge Agelas nakamurai |
Q40609440 | Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing |
Q40064472 | Analyses of MT1-MMP activity in cells. |
Q39743200 | Analysis of MMP-dependent cell migration and invasion. |
Q89602768 | Autofluorescence Lifetime Reports Cartilage Damage in Osteoarthritis |
Q42024098 | Basal localization of MT1-MMP is essential for epithelial cell morphogenesis in 3D collagen matrix |
Q40488978 | CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase. |
Q39647831 | CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. |
Q73314090 | Callysponginol sulfate A, an MT1-MMP inhibitor isolated from the marine sponge Callyspongia truncata |
Q42450915 | Characterization of the interface between normal and transformed epithelial cells |
Q22010479 | Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family |
Q34214375 | Clusterin, an abundant serum factor, is a possible negative regulator of MT6-MMP/MMP-25 produced by neutrophils. |
Q93492077 | Collagenases and aggrecanases: understanding the role of non-catalytic domains in cartilage matrix breakdown |
Q40386580 | Competitive disruption of the tumor-promoting function of membrane type 1 matrix metalloproteinase/matrix metalloproteinase-14 in vivo. |
Q42952060 | Cytoplasmic tail-dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity. |
Q71652664 | Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond |
Q41190792 | Degradation of interleukin 1beta by matrix metalloproteinases. |
Q39498219 | Detection of cartilage matrix degradation by autofluorescence lifetime. |
Q37086127 | Development of a specific affinity-matured exosite inhibitor to MT1-MMP that efficiently inhibits tumor cell invasion in vitro and metastasis in vivo |
Q39489538 | Dimerization of MT1-MMP during cellular invasion detected by fluorescence resonance energy transfer |
Q33586567 | Discoidin domain receptor 2 mediates collagen-induced activation of membrane-type 1 matrix metalloproteinase in human fibroblasts. |
Q88405318 | Discoidin domain receptors: Microenvironment sensors that promote cellular migration and invasion |
Q67569079 | Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts |
Q61796293 | Epithelial polarization in 3D matrix requires DDR1 signaling to regulate actomyosin contractility |
Q71530834 | Fluorescence quenching studies of matrix metalloproteinases (MMPs): evidence for structural rearrangement of the proMMP-2/TIMP-2 complex upon mercurial activation |
Q74052238 | Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor |
Q28215016 | Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. |
Q33872971 | Human membrane type-4 matrix metalloproteinase (MT4-MMP) is encoded by a novel major transcript: isolation of complementary DNA clones for human and mouse mt4-mmp transcripts. |
Q64082859 | Hypergravity and microgravity exhibited reversal effects on the bone and muscle mass in mice |
Q68269475 | Identification of rabbit uterine cervical procollagenase activator as rabbit matrix metalloproteinase 3 (stromelysin) |
Q73860469 | Importance of matrix metalloproteinases in human trophoblast invasion |
Q42881603 | Inhibition of Shedding of Low-Density Lipoprotein Receptor-Related Protein 1 Reverses Cartilage Matrix Degradation in Osteoarthritis. |
Q73995916 | Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells |
Q53384135 | Invasive potential of human rheumatoid tenosynovial cells is in part MT1-MMP dependent. |
Q41154686 | Involvement of tissue inhibitors of metalloproteinases (TIMPS) during matrix metalloproteinase activation. |
Q42841372 | MT-LOOP-dependent localization of membrane type I matrix metalloproteinase (MT1-MMP) to the cell adhesion complexes promotes cancer cell invasion |
Q91832231 | MT1-MMP-dependent cell migration: proteolytic and non-proteolytic mechanisms |
Q36141763 | MT1-MMP: a potent modifier of pericellular microenvironment. |
Q80382794 | MT1-MMP: an enzyme with multidimensional regulation |
Q42479308 | Matrix metalloproteinase expression and function during fin regeneration in zebrafish: analysis of MT1-MMP, MMP2 and TIMP2. |
Q77361829 | Matrix metalloproteinase-2 in a murine model of infantile-type polycystic kidney disease |
Q77380951 | Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms |
Q71690228 | Matrix metalloproteinases and TIMPS in cultured C57BL/6J-cpk kidney tubules |
Q47994526 | Matrix metalloproteinases and their inhibitors in human vitreous. |
Q35015124 | Matrix metalloproteinases in cancer. |
Q33880837 | Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase. |
Q35572266 | Membrane-type 1 matrix metalloproteinase and cell migration. |
Q24304420 | Membrane-type 1 matrix metalloproteinase cytoplasmic tail-binding protein-1 is a new member of the Cupin superfamily. A possible multifunctional protein acting as an invasion suppressor down-regulated in tumors |
Q24290409 | Membrane-type 6 matrix metalloproteinase (MT6-MMP, MMP-25) is the second glycosyl-phosphatidyl inositol (GPI)-anchored MMP |
Q28085194 | Membrane-type matrix metalloproteinases: Their functions and regulations |
Q34030049 | Metalloproteinase binding proteins: WO2009097397. |
Q51837034 | Metalloproteinases in Rheumatoid Arthritis: Potential Therapeutic Targets to Improve Current Therapies. |
Q38378540 | Metalloproteinases: potential therapeutic targets for rheumatoid arthritis. |
Q46537585 | Palmitoylation at Cys574 is essential for MT1-MMP to promote cell migration. |
Q77228964 | Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface |
Q41677243 | Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase. |
Q72315437 | Progesterone increases the production of tissue inhibitor of metalloproteinases-2 in rabbit uterine cervical fibroblasts |
Q22009926 | Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins |
Q41175511 | Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not an MMP. |
Q36536688 | Selective Inhibition of Membrane Type 1 Matrix Metalloproteinase Abrogates Progression of Experimental Inflammatory Arthritis: Synergy With Tumor Necrosis Factor Blockade |
Q42160569 | Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate |
Q71942195 | Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases |
Q27666418 | The Dimer Interface of the Membrane Type 1 Matrix Metalloproteinase Hemopexin Domain: CRYSTAL STRUCTURE AND BIOLOGICAL FUNCTIONS |
Q28504785 | The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis |